Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Asset Utilization Ratio: 2021-2024

Historic Asset Utilization Ratio for Oncology Institute (TOI) over the last 4 years, with FY2024 value amounting to 2.06.

  • Oncology Institute's Asset Utilization Ratio rose 4429.63% to 0.69 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.69, marking a year-over-year increase of 4429.63%. This contributed to the annual value of 2.06 for FY2024, which is 4958.95% up from last year.
  • Per Oncology Institute's latest filing, its Asset Utilization Ratio stood at 2.06 for FY2024, which was up 4958.95% from 1.38 recorded in FY2023.
  • Over the past 5 years, Oncology Institute's Asset Utilization Ratio peaked at 2.06 during FY2024, and registered a low of 1.09 during FY2022.
  • Moreover, its 4-year median value for Asset Utilization Ratio was 1.44 (2023), whereas its average is 1.51.
  • Per our database at Business Quant, Oncology Institute's Asset Utilization Ratio tumbled by 2803.22% in 2022 and then surged by 4958.95% in 2024.
  • Over the past 4 years, Oncology Institute's Asset Utilization Ratio (Annual) stood at 1.51 in 2021, then dropped by 28.03% to 1.09 in 2022, then rose by 26.84% to 1.38 in 2023, then skyrocketed by 49.59% to 2.06 in 2024.
  • Its Asset Utilization Ratio was 2.06 in FY2024, compared to 1.38 in FY2023 and 1.09 in FY2022.